Literature DB >> 33779268

Prevalence of Atrial Fibrillation and Thromboembolic Risk in Wild-Type Transthyretin Amyloid Cardiomyopathy.

Syed Bukhari1, Amr F Barakat1, Yvonne S Eisele1, Ricardo Nieves1, Sandeep Jain1, Samir Saba1, William P Follansbee1, Amy Brownell1, Prem Soman1.   

Abstract

Entities:  

Keywords:  amyloidosis; atrial fibrillation; thromboembolism

Mesh：

Year:  2021        PMID： 33779268     DOI： 10.1161/CIRCULATIONAHA.120.052136

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  Recovery of sinus rhythm by tafamidis in patients with wild-type transthyretin amyloid cardiomyopathy with atrial arrhythmias.

Authors:  Yoshitaka Isotani; Eisuke Amiya; Junichi Ishida; Masato Ishizuka; Masaru Hatano; Koki Nakanishi; Masao Daimon; Issei Komuro
Journal:  Oxf Med Case Reports       Date:  2022-02-19

2.  Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.

Authors:  Maria Papathanasiou; Aiste-Monika Jakstaite; Sara Oubari; Johannes Siebermair; Reza Wakili; Julia Hoffmann; Alexander Carpinteiro; Tim Hagenacker; Andreas Thimm; Christoph Rischpler; Lukas Kessler; Tienush Rassaf; Peter Luedike
Journal:  ESC Heart Fail       Date:  2022-02-17

3.  Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients.

Authors:  Mathijs O Versteylen; Maaike Brons; Arco J Teske; Marish I F J Oerlemans
Journal:  Biomedicines       Date:  2022-07-22

4.  Pitfalls of the Semi-Quantitative Analyzing 99mTc-Pyrophosphate Planar Images for Diagnosing Transthyretin Cardiac Amyloidosis: A Possible Solution.

Authors:  Yuankai Zhu; Ruping Pan; Dan Peng; Qingjian Dong; Xiaohua Zhu
Journal:  Diagnostics (Basel)       Date:  2022-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.